Get your first prescription at no cost Subject to eligibility. Restrictions may apply.
Not available to patients paying cash.
Myrbetriq is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Getting Started With Myrbetriq

Understanding what to expect is key

Your healthcare professional (HCP) may prescribe Myrbetriq® (mirabegron) for you to help your symptoms of overactive bladder (OAB) including urgency, frequency and leakage. When beginning any treatment, it's important to know what to expect.

To give Myrbetriq a chance to work, take it once daily as prescribed by your HCP and be patient:

  • For some people in clinical trials for Myrbetriq, it took 4-8 weeks to start seeing an improvement in their OAB symptoms
  • Further improvement may be seen within 12 weeks

    Your results may vary.

In clinical trials, those taking Myrbetriq made fewer bathroom trips and had fewer leaks than those not taking Myrbetriq. So to review, a good way to manage your OAB symptoms is to follow these 3 guidelines:

1

Follow directions

If your HCP has prescribed Myrbetriq, take it as prescribed and swallow the tablet whole. Do not chew, break, or crush the tablet.

2

Think “daily”

It is important that you take Myrbetriq once daily as prescribed by your HCP. Don't take your medicine only when your symptoms are especially bothersome, or when you're about to have a big event or take a long car ride.

3

Stick with it

In clinical trials, it took 4-8 weeks to start seeing an improvement in OAB symptoms. So, stick with it. Those taking Myrbetriq in these trials made fewer trips to the bathroom and had fewer leaks than those not taking Myrbetriq. Your results may vary.

Dr. Staskin on how Myrbetriq may help overactive bladder Play Button Icon

Myrbetriq: How to Get Started

Myrbetriq is approved to treat OAB with symptoms of urgency, frequency and leakage. David Staskin, MD, talks about what you may expect while taking Myrbetriq.

people like this

Myrbetriq: How to Get Started

Myrbetriq is approved to treat OAB with symptoms of urgency, frequency and leakage. David Staskin, MD, talks about what you may expect while taking Myrbetriq.

Steps Along Your Treatment Journey

Developing a Myrbetriq® (mirabegron) treatment plan that may work for you takes time. Myrbetriq Mylestones are four easy-to-remember steps that will make that time more manageable and help you get off to a good start. So, stick with these Mylestones and talk to your doctor:

  • Day 1 Set goals

    Talk to your doctor about your treatment goals and what to expect when starting treatment. Keep in mind that it may take 4-8 weeks to start seeing an improvement in your OAB symptoms. Your results may vary.

  • Day 30 Track your progress

    You may begin noticing the effects of Myrbetriq now. See the progress you're making by tracking your OAB symptoms and sharing with your doctor.

  • Day 60 Stay the course!

    For some people taking Myrbetriq, it took up to 12 weeks to notice a difference. Your results may vary. Consider scheduling a follow-up visit with your doctor at the 12 week Mylestone to discuss how Myrbetriq is working for you.

  • Day 90 Talk with your doctor

    Remember, the key to your treatment plan may be staying persistent, so be sure to stay in touch with your doctor to see how your treatment plan is working for you.

Next Section
Savings &
Support
Prev Section
Talking With
Your Doctor

Use of Myrbetriq

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to VITALS®.

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide